Texas Oncology Milestones
Texas Oncology physicians bring the power and resources of a world-class network to bear for patients fighting cancer.
- 345 physicians practicing medicine at Texas Oncology
- 86,000 new patients who access care annually
- 1,275 patients who participated in clinical research trials last year
- 46 FDA-approved therapies developed
- 25 years helping Texans fight cancer
- Medical Oncology Group, the nation’s largest private practice of 21 medical oncologists, reorganizes as a professional association called Texas Oncology, P.A.
- First cancer center opens in Plano, creating first full-service oncology practice under one roof.
- Practice expands to Sherman-Denison.
- Gynecologic oncology specialty added.
- Texas Oncology forms the Physician Reliance Network, a management company to coordinate public financing, growth, and expansion of Texas Oncology’s network.
- Texas Oncology forms statewide clinical research network.
- Launches Texas Oncology Pharmacy Services.
- Physician Reliance Network and Texas Oncology develop second major transplant center. First was established by a group of Texas Oncology physicians in 1982, before practice was officially founded.
- Pediatric oncology specialists join the network in Dallas.
- Texas Oncology–Baylor Charles A. Sammons Cancer Center begins using a PET/CT scanner to increase accuracy of diagnostic imaging.
- Texas Oncology Pharmacy Services structured so every practice has a pharmacist to answer questions, on-site or remotely.
- Texas Oncology clinical trial leads to FDA approval of Doxil for treatment of ovarian cancer.
- Genetic Risk Evaluation And Testing Program launches to identify patients who have a higher risk of developing cancer because of inherited genes.
- Texas Breast Specialists launches, dedicated to breast health.
- Texas Oncology creates partnership with Radiation Therapy Oncology Group, expanding reach of leading-edge radiation clinical trials.
- Practices in Dallas and Tyler are among the first free-standing cancer centers to use NovalisTM stereotactic radiosurgery system and RapidArc radiotherapy.
- Texas Urology Specialists launches to provide overall urological care.
- Texas Oncology clinical trials lead to docetaxel and cyclophosphamide (TC) chemotherapy regimen, which became the most widely-used breast cancer treatment.
- Texas Oncology–Baylor Charles A. Sammons Cancer Center is one of first sites in country approved to treat patients with new Provenge® immunotherapy vaccine for advanced prostate cancer.
- Texas Oncology physicians lead Phase II clinical trial testing iniparib, a drug with PARP inhibiting activity, to treat metastatic triple negative breast cancer.
- Texas Oncology, US Oncology, and Baylor Healthcare System announce plans to bring the first proton therapy center to North Texas.
- Texas Oncology is first in Texas to treat male breast cancer using SAVI high dose rate brachytherapy technology.
- Texas Oncology is nation’s largest physician practice exclusively focused on cancer treatment and research, with 345 physicians, 2,900 employees, and 86,000 new patients annually.
Back to Newsletter | Subscribe to Our Newsletter